Related Experiment Video
Updated: Jun 18, 2026
04:34
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
[Our experience with chordoma treatment].
P Brindza1, R Chaloupka, R Grosman
1Ortopedická klinika LF MU a FN Brno-Bohunice. brindza.p@seznam.cz
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca
|November 17, 2009
Summary
Chordomas are rare spinal tumors often diagnosed late. Early diagnosis and en bloc resection improve prognosis, though recurrence is common. Radiotherapy is recommended post-surgery.
Area of Science:
- Orthopedic Surgery
- Neurosurgery
- Oncology
Context:
- Chordomas are rare, slow-growing bone tumors originating from notochordal remnants.
- They most commonly occur in the sacrum and spine, presenting diagnostic and therapeutic challenges.
- Delayed diagnosis is frequent, particularly for sacral chordomas, impacting treatment outcomes.
Purpose:
- To evaluate diagnostic and surgical management strategies for spinal chordomas.
- To assess post-operative complications, tumor recurrence rates, and patient survival.
- To analyze treatment outcomes based on tumor location (mobile spine vs. sacrum).
Summary:
- A retrospective study of 20 patients (1989-2002) with spinal chordomas.
- Treatment involved combined antero-posterior procedures for mobile spine chordomas and dorsal approaches for sacral chordomas.
- Average survival was 63 months; 40% survived over five years. Recurrence and wound infection were noted complications.
Impact:
- Highlights the importance of magnetic resonance imaging (MRI) for diagnosis and surgical planning.
- Emphasizes the effectiveness of combined antero-posterior procedures for mobile spine chordomas.
- Underscores the high risk of local recurrence and the benefit of post-operative radiotherapy.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.